<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2010-14-1-81-85</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1208</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЖУРНАЛ В ЖУРНАЛЕ. АКТУАЛЬНЫЕ ПРОБЛЕМЫ УРОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>JOURNAL IN THE JOURNAL. ACTUAL PROBLEMS OF UROLOGY</subject></subj-group></article-categories><title-group><article-title>ЗНАЧЕНИЕ  КЛАССИЧЕСКИХ  МОРФОЛОГИЧЕСКИХ  ПРИЗНАКОВ  ДЛЯ  ПРОГНОЗИРОВАНИЯ  ТЕЧЕНИЯ  ПЕРЕХОДНО-КЛЕТОЧНОГО  РАКА  МОЧЕВОГО  ПУЗЫРЯ</article-title><trans-title-group xml:lang="en"><trans-title>THE VALUE OF CLASSICAL MORPHOLOGICAL FEATURES TO PREDICT THE  COURSE OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Завьялова</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Zavialova</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра урологии</p><p>197089, ул. Льва Толстого, д.17, тел. 8921-759-24-04.</p></bio><email xlink:type="simple">dr.zavialova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корнеев</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Korneev</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра урологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ягмуров</surname><given-names>О. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Yagmurov</surname><given-names>O. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра патологической  анатомии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аль-Шукри</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Al-Shukri</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра урологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>10</day><month>01</month><year>2010</year></pub-date><volume>14</volume><issue>1</issue><fpage>81</fpage><lpage>85</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Завьялова Е.С., Корнеев И.А., Ягмуров О.Д., Аль-Шукри А.С., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Завьялова Е.С., Корнеев И.А., Ягмуров О.Д., Аль-Шукри А.С.</copyright-holder><copyright-holder xml:lang="en">Zavialova E.S., Korneev I.A., Yagmurov O.D., Al-Shukri A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1208">https://journal.nephrolog.ru/jour/article/view/1208</self-uri><abstract><p>ЦЕЛЬ ИССЛЕДОВАНИЯ: исследование прогностической ценности определения глубины инвазии и степени дифференцировки рака мочевого пузыря согласно рекомендациям ВОЗ редакций 1973 и 2004 гг. ПАЦИЕНТЫ И МЕТОДЫ. Ретроспективно изучены материалы клинического обследования 115 больных (соотношение мужчин и женщин составило 9:1, средний возраст пациентов – 63±1,9 года), оперированных по поводу переходно-клеточного рака мочевого пузыря (63 (54,8%) – трансуретральная резекция, 14 (12,2%) – радикальная цистэктомия, 38 (33%) – диагностическая трансуретральная (ТУР) биопсия с последующей лучевой терапией. При постхирургическом гистопатологическом исследовании определяли глубину инвазии и степень дифференцировки рака с позиций двух классификационных систем и сопоставляли полученные результаты с послеоперационной выживаемостью больных. РЕЗУЛЬТАТЫ. Низкую выживаемость наблюдали у пациентов с расположением карцином в области треугольника Льето (rs=0,64; p=0,02), множественными опухолями (rs=0,62; p=0,024), рецидивирующим течением рака (rs=0,69; p=0,018). Продолжительность жизни пациентов сокращалась при увеличении глубины прорастания рака мочевого пузыря (r=0,55; p=0,01), а также с возрастанием степени анаплазии карцином при оценке согласно классификации 1973 г. В соответствии с классификацией ВОЗ 2004 г. выживаемость больных с низкодифференцированным раком была достоверно короче по сравнению с пациентами с высокодифференцированными карциномами (t=3,35; p=0,007; U=2,00; p=0,017). ЗАКЛЮЧЕНИЕ. Исследование показало, что категории двух принятых на сегодняшний день классификационных систем предоставляют разную информацию относительно течения рака мочевого пузыря и целесообразно использовать обе систематизации.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM of the study the prognostic value of determining the depth of invasion and degree of differentiation of bladder cancer according to WHO recommendations editions 1973 and 2004. PATIENTS AND METHODS. Retrospectively studied the materials of clinical examination 115 patients (ratio of men to women was 9:1, mean age - 63 ± 1,9 years) operated on for transitional-cell bladder cancer (63 (54,8%) - transurethral resection, 14 (12.2%) radical cystectomy, 38 (33%) diagnostic TUR-biopsy followed by radiotherapy. During postsurgical histopathologic examination determined the depth of invasion and degree of differentiation of cancer from the standpoint of the two classification systems and to compare these results with postoperative survival. RESULTS. The low survival rate observed in patients with carcinomas located in the area of the triangle is pouring (rs = 0,64; p = 0,02), multiple tumors (rs = 0.62; p = 0,0.4), recurrent course of cancer (rs = 0.69; p = 0.018). The life expectancy of patients declined with increasing depth of germination of bladder cancer (r = 0.55; p = 0.01), as well as with increasing degree of anaplasia of carcinomas in the evaluation according to the classification in 1973 According to the WHO classification in 2004 the survival rate of patients with poorly differentiated cancer was significantly shorter compared with patients with highly differentiated carcinomas (t = 3.35; p = 0.007; U = 2.00; p = 0.017). CONCLUSION. The study showed that the two categories taken to date classification systems provide a variety of information regarding the flow of bladder cancer and should be used both systematization.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>переходно-клеточный рак мочевого пузыря</kwd><kwd>классификация ВОЗ 2004 г</kwd><kwd>прогноз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>transitional cell bladder cancer</kwd><kwd>the WHO classification of 2004.</kwd><kwd>Prognosis.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss 2002:199–202</mixed-citation><mixed-citation xml:lang="en">Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss 2002:199–202</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mostofi FK, Davis CJ, Sesterhenn I. Histological Typing of Urinary Bladder Tumors. Berlin: Springer 1999:20–120</mixed-citation><mixed-citation xml:lang="en">Mostofi FK, Davis CJ, Sesterhenn I. Histological Typing of Urinary Bladder Tumors. Berlin: Springer 1999:20–120</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Epstein JI, Amin MB, Reuter VE et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22:1435–1448</mixed-citation><mixed-citation xml:lang="en">Epstein JI, Amin MB, Reuter VE et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22:1435–1448</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gonul II, Poyraz A, Unsal C, Acar C, Alkibay T. Comparison of 1998 WHO/ ISUP and 1973 WHO classification for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases. Urol Int 2007; 78(4):338–44</mixed-citation><mixed-citation xml:lang="en">Gonul II, Poyraz A, Unsal C, Acar C, Alkibay T. Comparison of 1998 WHO/ ISUP and 1973 WHO classification for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases. Urol Int 2007; 78(4):338–44</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez-Beltran A, Montironi R. Non-invasive urothelial neoplasm: according to the most recent WHO classification. Eur Urol 2004; 46(2):170–176</mixed-citation><mixed-citation xml:lang="en">Lopez-Beltran A, Montironi R. Non-invasive urothelial neoplasm: according to the most recent WHO classification. Eur Urol 2004; 46(2):170–176</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Alvarez-Kindelan J, Campos-Hernandez JP, Lopez-Beltran A, Requena-Tapia MJ. WHO 2004 classification of bladder tumors: summary and comments. Actas Urol Esp 2007;31(9):978–988</mixed-citation><mixed-citation xml:lang="en">Alvarez-Kindelan J, Campos-Hernandez JP, Lopez-Beltran A, Requena-Tapia MJ. WHO 2004 classification of bladder tumors: summary and comments. Actas Urol Esp 2007;31(9):978–988</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
